Best Greenblatt Magic Formula Stocks in Biotechnology for 2026
High earnings yield plus high ROIC: Joel Greenblatt's Magic Formula for market-beating returns.
Biotechnology spans the cash-generative commercial-stage companies and the pre-revenue clinical-stage cohort. Composite scoring is harsh on cash-burning names via the Health pillar (runway, cash to market cap); commercial-stage biotechs surface through the Quality pillar (gross margin, ROIC) and Valuation pillar.
Data as of (updated daily)
Top 20 Biotechnology stocks by composite score
| # | Ticker | Name | Composite |
|---|---|---|---|
| 1 | OTLK.US | OUTLOOK THERAPEUTICS INC | 50.4 |
| 2 | BVXP.LSE | Bioventix | 54.1 |
| 3 | RIGL.US | Rigel Pharmaceuticals Inc | 67.8 |
| 4 | QTTB.US | Q32 Bio Inc | 48.6 |
| 5 | FBIO.US | Fortress Biotech Inc | 58.8 |
| 6 | ENLV.TA | Enlivex Therapeutics Ltd | 52.7 |
| 7 | ABUS.US | Arbutus Biopharma Corp | 64.5 |
| 8 | ZVRA.US | Zevra Therapeutics Inc. | 66.0 |
| 9 | A1SN34.SA | Ascendis Pharma A/S | 61.1 |
| 10 | ORMP.US | Oramed Pharmaceuticals Inc | 50.0 |
| 11 | ORMP.TA | Oramed Pharmaceuticals Inc | 51.0 |
| 12 | TBPH.US | Theravance Biopharma Inc | 55.4 |
| 13 | VXRT.US | Vaxart Inc | 66.4 |
| 14 | 1530.HK | 3SBio Inc | 78.7 |
| 15 | CGEN.US | Compugen | 47.8 |
| 16 | INVA.US | Innoviva Inc | 63.3 |
| 17 | CRMD.US | CorMedix Inc | 68.0 |
| 18 | 2509.HK | Qyuns Therapeutics Co Ltd | 65.9 |
| 19 | CUV.AU | Clinuvel Pharmaceuticals Ltd | 63.0 |
| 20 | PLX.US | Protalix Biotherapeutics Inc | 68.1 |
Customise the greenblatt magic formula stocks + biotechnology screen
The full screener applies both filters and lets you stack 30+ more on top: market cap, country, dividend yield, and the four pillar scores.
Open in screener →Greenblatt Magic Formula Stocks in other industries
Other strategies in Biotechnology
Browse the hub pages
Methodology: How we score stocks. Data refreshed nightly around 03:30 ET. This page lists the top 20 by composite score within the Biotechnology industry; use the screener for the full ranked list.